Mkango Donates State of the Art Anaesthetic Machine to the Mercy James Centre at the Queen Elizabeth Central Hospital in Blan...
June 01 2020 - 01:00AM
Mkango Resources Ltd. (AIM/TSX-V: MKA) (the "Company" or "Mkango")
is pleased to announce the donation of a new state of the art
Mindray WATO EX-20 anaesthetic machine to the Mercy James Centre at
the Queen Elizabeth Central Hospital in Blantyre, Malawi.
The new anaesthetic machine will help enable the
Queen Elizabeth Central Hospital to set up a new operating theatre
for emergency operations, specifically for patients who are
suspected of having the COVID 19 virus.
Mr Alexander Lemon, President of Mkango
Resources stated:
“We are delighted to donate this anaesthetic
machine to the Mercy James Centre at the Queen Elizabeth Central
Hospital to help fight the growing pandemic of COVID 19 in Malawi.
We hope that it will potentially help save many lives in the coming
years. Mkango is committed to supporting the country in which it
operates, as it moves towards the sustainable development of the
Songwe Hill rare earths project in Malawi.”
Professor Eric Borgstein, Consultant
Pediatric Surgeon at the Queen Elizabeth Central Hospital and
Professor of Surgery at the University of Malawi College of
Medicine, stated:
“Surgical emergencies cannot wait. While the
hospital is struggling to respond to the new demands of the
Coronavirus epidemic, the provision of care for patients with acute
surgical conditions must go on! It is gratifying to see
Mkango Resources making such a timely donation, which will benefit
all our various patients, not only now but for years to come. This
new anaesthetic machine will enable us to set up a separate
operating theatre for patients who may be COVID infected; thereby
keeping the existing theatres free for the many daily surgical
emergencies. A great example of appropriate, effective and useful
assistance to our hospital.”
Dr Singatiya Stella Chikumbanje,
Consultant Anaesthetist at Queen Elizabeth Central Hospital,
stated:
“We are grateful for the donation of this
anaesthetic machine. The arrival of the anaesthetic machine is very
timely, as it will help in our provision of safe anaesthesia for
our patients during the COVID period and beyond. Hopefully
other companies will emulate Mkango’s generosity and allow us to
provide improved care to all our patients.”
The Mindray WATO EX-20 anaesthetic machine was
purchased from Worldwide Pharmaceutical Distributors who are agents
and distributors for Mindray in Malawi.
About The Mercy James Centre for
Paediatric Surgery and Intensive Care (MJC) and Queen Elizabeth
Hospital
The MJC is located in the grounds of the 1000
bed Queen Elizabeth Central Hospital, the largest public and
teaching hospital in Malawi. The MJC was developed by Raising
Malawi, a non-government organisation founded by Madonna, in
collaboration with the Malawian health ministry.
About Mkango
Mkango's primary business is exploration for
rare earth elements and associated minerals in the Republic of
Malawi, a country whose hospitable people have earned it a
reputation as “the warm heart of Africa”. The Company holds
interests in four exclusive prospecting licenses in Malawi: the
Phalombe licence, the Thambani licence, the Chimimbe Hill licence
and the Mchinji licence.
The main exploration target in the 51% held
Phalombe licence is the Songwe Hill rare earths deposit. This
features carbonatite-hosted rare earth mineralisation and was
subject to previous exploration in the late 1980s. Mkango completed
an updated Pre-Feasibility Study for the project in November 2015
and a Feasibility Study is currently underway, the initial phases
of which included a 10,900 metre drilling programme and an updated
mineral resource estimate, announced in February 2019. In March
2019, the Company announced receipt of a £7 million (C$12.3
million) investment from Talaxis to fund completion of the
Feasibility Study. Following completion of the Feasibility Study,
Talaxis has an option to acquire a further 26% interest in Songwe
by arranging financing for project development including funding
the equity component thereof.
The main exploration targets in Mkango’s
remaining three 100% held licences are, in the Thambani licence,
uranium, niobium, tantalum and zircon, in the Chimimbe Hill
licence, nickel and cobalt, and in the Mchinji licence, rutile,
nickel, cobalt, base metals and graphite.
Mkango also holds a 75.5% interest in Maginito
with the balance owned by Talaxis. Maginito is focused on
downstream opportunities relating to the rare earths supply chain,
in particular, recycling and other innovative technologies for the
production of neodymium alloy powders and magnets used in electric
vehicles, wind turbines and other industries geared to
decarbonisation of the economy.
|
|
For further information on Mkango, please
contact: |
|
|
Mkango Resources
Limited |
William Dawes |
Alexander Lemon |
Chief Executive Officer |
President |
will@mkango.ca |
alex@mkango.ca |
Canada: +1 403 444 5979 |
|
|
|
www.mkango.ca |
|
@MkangoResources |
|
|
|
Blytheweigh |
Financial Public Relations |
Tim Blythe, Camilla Horsfall |
UK: +44 207 138 3204 |
|
|
SP Angel Corporate Finance
LLP |
Nominated Adviser and Joint Broker |
Jeff Keating, Caroline Rowe |
UK: +44 20 3470 0470 |
|
|
Alternative Resource
Capital |
Joint Broker |
Alex Wood, Rob Collins |
UK: +44 20 7186 9004; +44 20 7186 9001 |
|
|
The TSX Venture Exchange has neither
approved nor disapproved the contents of this press release.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This press release does not constitute an offer
to sell or a solicitation of an offer to buy any equity or other
securities of the Company in the United States. The securities of
the Company will not be registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act”) and
may not be offered or sold within the United States to, or for the
account or benefit of, U.S. persons except in certain transactions
exempt from the registration requirements of the U.S. Securities
Act.
Mkango Resources (TSXV:MKA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Mkango Resources (TSXV:MKA)
Historical Stock Chart
From Mar 2023 to Mar 2024